EQUITY

12 Months Ended

Jun. 30, 2025

EQUITY

EQUITY

NOTE 9 – EQUITY

Common Stock

As of June 30, 2025 and 2024, the Company had 5,000,000,000 shares of common stock authorized with a par value of $0.00001. There were 695,746,625 and 524,853,304 shares issued and outstanding as of June 30, 2025 and 2024, respectively.

Series A Preferred Stock

There are 100,000,000 shares authorized as preferred stock, of which 3,500,000 are designated as Series A preferred stock having a par value of $0.00001 per share. The Series A preferred stock has the following rights:

· Voting: The preferred shares shall be entitled to 1,000 votes to every one share of common stock.

· Dividends: The Series A preferred stockholders are treated the same as the common stockholders except at the dividend on each share of Series A convertible preferred stock is equal to the amount of the dividend declared and paid on each share of common stock multiplied by the Conversion Rate.

· Conversion: Each share of Series A Preferred Stock is convertible, at the option of the holder thereof, at any time into shares of Common Stock on a 1:1,000 basis.

· The shares of Series A Preferred Stock are redeemable at the option of the Corporation upon not less than 30 days written notice to the holders. It is not mandatorily redeemable.

As of June 30, 2025 and 2024, the Company had 664,996 and 705,895 shares of Series A preferred stock issued and outstanding, respectively.

Series B Preferred Stock

On March 25, 2021, the Certificate of Designation for the Series B Preferred was recorded by the State of Nevada. There are 100,000,000 shares authorized as preferred stock, of which 1,000,000 are designated as Series B Preferred Stock having a par value of $0.00001 per share. The Series B preferred stock is not convertible, grants 5,000 votes and no liquidation preference.

Stock Options

A summary of the Company’s stock options activity is as follows:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Contractual Term (in years)		Aggregate Intrinsic Value
Outstanding at June 30, 2023		21,250,000		$	0.12		0.97
Granted		-
Exercised		-			-
Canceled		-			-
Outstanding at June 30, 2024		21,250,000		$	0.12		0.13		-
Granted		-
Exercised		-			-
Canceled		(21,250,000	)		-
Outstanding at June 30, 2025		-						$	-
Exercisable at June 30, 2025		-						$	-

Significant inputs and results arising from the Black-Scholes process are as follows for the options:

Quoted market price on valuation date	$0.169 - $0.23
Exercise prices	$0.12
Range of expected term	1.55 Years – 2.49 Years
Range of market volatility:
Range of equivalent volatility	181.21% - 275.73%
Range of interest rates	0.20% - 1.08%

Warrants

As of June 30, 2025 and 2024, the Company had 111,568,828 and 118,968,828 warrants outstanding. The warrants have a term of two to five years, and an exercise price range from $0.021 and $0.1187. The Company evaluated the warrants under ASC 815, Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair values. As of June 30, 2025, the weighted average remaining useful life of the warrants was 1.90. The warrants are detailed as follows:

Number of Warrants	Number of Warrants			Weighted- Average Exercise Price		Weighted- Average Contractual Term (in years)		Aggregate Intrinsic Value
Outstanding at June 30, 2023		104,802,161		$	0.11		3.79	$	-
Granted		15,000,000		$	0.01		3.00
Exercised		-
Canceled		(833,333	)
Outstanding at June 30, 2024		118,968,828		$	0.09		2.50	$	-
Granted		7,900,000		$	0.01		3.00
Exercised		-
Canceled		(15,300,000	)
Outstanding at June 30, 2025		111,568,828		$	0.095		1.90	$	-
Vested at June 30, 2025		111,568,828		$	0.095		1.90	$	-
Exercisable at June 30, 2025		111,568,828		$	0.095		1.90	$	-